Candesartan Cilexetil + Tizanidine Hydrochloride
This interaction is documented in this data source.
- Candesartan Cilexetil
- Checked as Candesartan
- Tizanidine Hydrochloride
- Checked as Tizanidine
What is documented
-
Synergy
Majorvia Candesartan and Tizanidine
What happens
Tizanidine may potentiate the hypotensive effect of some medications secondary to its alpha-2 adrenergic activity.
What to do
A lower initial dosage and cautious dosage titration should be considered when tizanidine is initiated in patients receiving hypotensive medications. Although single doses of less than 8 mg of tizanidine have not been shown effective for spasticity in controlled clinical studies, it may be prudent to initiate treatment with 4 mg doses and gradually increase in 2 to 4 mg increments until optimum effect is achieved. The dose can be repeated at 6 to 8 hour intervals as needed, up to a maximum of three doses in 24 hours and a total daily dosage of 36 mg. However, experience with single doses exceeding 8 mg and daily doses exceeding 24 mg is limited. Close monitoring for development of hypotension is recommended. Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.
1 source
- "Product Information. Zanaflex (tizanidine)." Acorda Therapeutics (2001):